Skip to main content
Day.News — Local News. Real Community.
MOORE COUNTY DAY NEWS
Local News. Real Community.

Health & Wellness

07/27/2026 · Moore County

Full Edition

Taco Bell Lettuce Under Investigation Amid Cyclosporiasis Outbreak

The Food and Drug Administration is investigating iceberg lettuce supplied to Taco Bell by Taylor Farms. This comes as a cyclosporiasis outbreak has sickened thousands across 34 states. Taco Bell has initiated a voluntary recall of potentially affected lettuce.

07/26/2026
Read Story
Health

Cyclospora Outbreak Linked to Taco Bell Lettuce in Five States

A Cyclospora outbreak has resulted in 1,644 reported illnesses across five states. Authorities attribute the infections to shredded iceberg lettuce served at Taco Bell restaurants. The CDC has issued a public health advisory regarding the consumption of this product.

07/27/2026

Health

Healthcare-Associated Infections Declined in 2023, CDC Reports

New data from the Centers for Disease Control and Prevention indicates a decline in healthcare-associated infections during 2023. These findings highlight changes within patient safety initiatives.

07/26/2026

Health

Wildfire Smoke, Food Recall, Immigration Officer Vetting Make News

Wildfire smoke blankets portions of the U.S., raising health concerns. A lettuce recall is underway due to links with a cyclosporiasis outbreak. Democrats seek information on immigration officer vetting following an Associated Press report.

07/27/2026

Health

FDA Identifies Lettuce Supplier in Parasite Outbreak Affecting Taco Bell Locations

A federal investigation linked a lettuce supplier to an outbreak of cyclospora cases reported in five states. The FDA identified a specific independent farm affiliated with Taylor Fresh Foods as the source. Taco Bell confirmed it received the affected produce.

07/27/2026

Health

FDA Approves Oral PCSK9 Inhibitor for Cholesterol Reduction

The U.S. Food and Drug Administration has approved Lipfendra (enlicitide), an oral medication designed to lower LDL cholesterol. This approval marks the first time an oral PCSK9 inhibitor has received authorization for use in adults with high cholesterol.

07/27/2026

Sponsored

Advertisement

Advertisement

Advertisement